Aofo Medical participates in pro-clear Friday medical special event

In the morning of August 19, 2022, "pro-clear appointment Friday" pharmaceutical enterprises special activities held in the first floor conference room of the municipal party committee. Huang Xiaowu, secretary of the municipal party committee, presided over the event, and Liu Junbo, vice chairman of the municipal committee and director of the municipal health committee, participated.

Ltd., Wang Qiang, general manager of Bengbu Fengyuan Tushan Pharmaceutical Co., Ltd., Chen Wanqing, general manager of Anhui Aerospace Biotechnology Co. Ltd., Wang Wei, chairman of Anhui Green Cross Pharmaceutical Co., Ltd. and Fang Bo, deputy general manager of Anhui Bengbu Minxin Pharmaceutical Co., Ltd. and other entrepreneurs have spoken, and they have actively put forward their opinions and suggestions around accelerating the application of product development and optimizing the environment for enterprise development.

Huang Xiaowu fully affirmed the contribution of the enterprises to Bengbu's economic development and livelihood protection. He pointed out that the biomedical industry is a rising sun industry, is Bengbu focus on the development of emerging leading industries. We should give full play to Bengbu's advantages in industrial base and medical resources, constantly optimize the development environment, accelerate the pace of innovation, reduce medical costs, strive to make enterprises bigger and stronger, and promote the synergistic development of the pharmaceutical industry and health care.

Huang Xiaowu stressed that we should adhere to the innovation drive, strengthen the research and development of drugs and medical devices, strive to develop products with core competitiveness, deepen the combination of medical industry, sort out the formation of an authoritative directory of innovative product promotion and application, increase publicity and promotion, and constantly enhance the market impact of the development of Bengbu's pharmaceutical industry and cultivate more new growth points. To form a synergy, establish an efficient interaction mechanism, support universities, medical institutions and enterprises to build and share laboratories and other research and development platforms, improve the development of pharmaceutical and mechanical research and development, clinical trial applications and industrial development system, and promote the transformation of new technologies and new product applications. To optimize the business environment, develop and improve policies and measures to encourage and support the development of the pharmaceutical industry, give full play to the advantages of existing medical institutions and pharmaceutical enterprises in Bengbu resources, strengthen business investment, further expand and extend the industrial chain, promote the pharmaceutical industry to accelerate the agglomeration, and make greater contributions to the efficient coordination of epidemic prevention and control and economic and social development.